Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Response Evaluation Criteria in Solid Tumors

fluorodeoxyglucose f18 has been researched along with Response Evaluation Criteria in Solid Tumors in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's32 (72.73)24.3611
2020's12 (27.27)2.80

Authors

AuthorsStudies
Du, R; Fang, H; Guo, F; Han, J; Kang, J; Lu, Z; Song, Q1
Cai, Z; Guo, W; Li, Y; Sun, K; Sun, X; Wang, Q; Wang, S; Xie, L; Xu, J1
Bogaerts, J; Litière, S1
Castello, A; Finocchiaro, G; Grizzi, F; Lopci, E; Mazziotti, E; Qehajaj, D; Rahal, D; Rossi, S; Toschi, L1
Bryce, R; Dujka, M; Hyman, DM; Jhaveri, K; Mann, G; Mayer, I; Meric-Bernstam, F; Piha-Paul, SA; Quinn, D; Saura, C; Shahin, S; Solit, DB; Stone, B; Ulaner, GA1
Evangelista, L; Pasello, G; Sepulcri, M1
Annovazzi, A; Carpano, S; Cognetti, F; Ferraresi, V; Giannarelli, D; Pasqualoni, R; Sciuto, R; Vari, S1
Gu, B; Lian, W; Liu, C; Lu, L; Pan, H; Song, S; Wang, M; Yang, Z; Yao, Z; Zhang, J; Zhang, Y1
Chung, YS; Kang, WJ; Kim, HS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ1
Ahac, V; Boc, N; Eickhoff, J; Jeraj, R; Simoncic, U; Skalic, K; Studen, A; Unk, M; Valentinuzzi, D; Vrankar, M; Zagar, I; Zupancic, Z1
Fukusumi, T; Hanamoto, A; Inohara, H; Isohashi, F; Kishikawa, T; Michiba, T; Ogawa, K; Seo, Y; Suzuki, M; Takemoto, N; Tamari, K; Tanaka, H; Tatsumi, M1
Arigami, T; Daisaki, H; Kitajima, K; Miwa, H; Nakajo, M; Nakamura, A; Ohtsuka, T; Toriihara, A; Yoshiura, T1
Chan, ATC; Chan, CML; Ho, WM; King, AD; Leung, L; Ma, B; Mo, F; Poon, A; Wang, K; Wong, SCC1
Abramson, JS; Advani, R; Ansell, S; Aurer, I; Bollard, C; Coiffier, B; de Vos, S; Dreyling, M; Elsayed, YA; Engert, A; Federico, M; Fisher, RI; Fortpied, C; Fowler, N; Gopal, A; Goy, A; Gribben, J; Hagenbeek, A; Hilden, P; Hutchings, M; Kaminski, MS; Kelly, K; Kloos, I; Kuruvilla, J; Leonard, JP; Little, RF; Meignan, M; Morschhauser, F; Pfreunschuh, M; Rademaker, J; Rule, S; Salles, G; Schoder, H; Schuster, SJ; Schwartz, LH; Sehn, LH; Seshan, VE; Seymour, JF; Smith, M; Takeshita, K; Thieblemont, C; Tobinai, K; Trneny, M; Valente, N; Van Oers, MHJ; Wilson, W; Witzig, TE; Younes, A; Zelenetz, AD; Zinzani, PL1
Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG1
Baratto, L; Davidzon, GA; Hatami, N; Iagaru, A; Mittra, ES; Moghbel, M1
Davidson, DJ; Elojeimy, S; Favinger, JL; Ha, AS; Hippe, DS; Lindberg, AW; Roth, ES1
Chan, AT; Chan, CM; Chan, KCA; Hui, EP; Kam, MK; King, A; Leung, SF; Li, L; Lo, YMD; Loong, H; Ma, B; Mo, F; Wang, K; Wong, A; Wong, SCC1
Katsuura, T; Kitajima, K; Kurahashi, Y; Odawara, S; Shinohara, H; Yamakado, K1
Hosoya, K; Ishibashi, M; Kaida, H; Kinoshita, T; Kitajima, K; Miyoshi, Y; Morita, T; Nakajo, M; Nakatani, K; Tani, A; Yamaguchi, K1
Behr, S; Cinar, P; Collisson, EA; Consunji, MV; Gao, K; Ko, AH; Ohliger, MA; Tempero, MA; Wang, ZJ; Yeh, BM1
Ahn, JS; Ahn, MJ; Choi, JY; Moon, SH; Park, K; Sun, JM1
Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N1
Ehlers, K; Gerke, O; Høilund-Carlsen, PF; Motschall, E; Vach, W1
Beer, L; Fabikan, H; Fazekas, A; Fuereder, T; Haug, AR; Herold, C; Hochmair, M; Kifjak, D; Mayerhoefer, ME; Prosch, H; Schwab, S; Schwabel, B; Wadsak, W1
Kotzerke, J1
Herrmann, K; Lordick, F; Ott, K; Schmidt, T1
Cho, KJ; Choi, SH; Kang, BC; Kim, JS; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Oh, JS; Roh, JL1
Akosman, C; Altunok, EC; Eren, OO; Ordu, C; Oyan, B; Selcuk, NA; Toklu, T1
Chou, PC; Ho, TY; Tsang, NM; Yang, CT; Yen, TC1
Kondo, T; Matoba, M; Oota, K; Shimode, Y; Tonami, H; Tuji, H1
Semiglazov, V1
Öztürk, H1
Chang, S; Kim, SJ; Koo, PJ; Kwak, JJ1
Advani, R; Fayad, L; Hankins, J; Juweid, M; Macapinlac, H; Meza, J; Minamimoto, R; Mottaghy, F; Quon, A; Vose, J1
Chan, I; Etemad-Rezai, R; Johnson, C; Landis, M; Louie, AV; Mattonen, SA; Palma, DA; Rodrigues, G; Senan, S; Ward, AD; Yeung, TP1
Jang, HJ; Kim, JH; Min, SJ1
Boas, FE; Do, RK; Gavane, S; Gonen, M; Kishore, S; Osborne, JR; Shady, W; Sofocleous, CT; Ulaner, GA; Ziv, E1
Cheng, Y; Gong, J; Guo, B; Huang, L; Ling, X; Shang, J; Tang, Y; Xiao, Z; Xu, H; Zhang, L1
Mattonen, SA; Palma, DA; Ward, AD1
Chang, JW; Cheng, NM; Chung, HW; Fang, YD; Ho, KC; Hou, MM; Liu, YC; Su, TP; Yang, CT; Yen, TC1
Kang, WJ; Kim, S; Kim, SW; Kim, YT; Nam, EJ; Yoon, JW1
Carrasquillo, JA; Do, RK; Gonen, M; Pandit-Taskar, N; Shady, W; Sofocleous, CT; Sotirchos, VS1
Doi, H; Funaguchi, N; Hasegawa, S; Kanemura, S; Kitajima, K; Kuribayashi, K; Mikami, K; Nakano, T; Shibata, E1

Reviews

9 review(s) available for fluorodeoxyglucose f18 and Response Evaluation Criteria in Solid Tumors

ArticleYear
Imaging endpoints for clinical trial use: a RECIST perspective.
    Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:11

    Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Neoplasms; Response Evaluation Criteria in Solid Tumors

2022
PET/CT and the Response to Immunotherapy in Lung Cancer.
    Current radiopharmaceuticals, 2020, Volume: 13, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors

2020
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Jul-01, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Consensus; Contrast Media; Disease Progression; Disease-Free Survival; Endpoint Determination; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Response Evaluation Criteria in Solid Tumors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden

2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Aug-01, Volume: 35, Issue:22

    Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms

2017
PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.
    Molecular imaging and biology, 2020, Volume: 22, Issue:1

    Topics: Biomarkers, Tumor; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2020
[Molecular imaging in oncological surgery: technical principles and importance].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2014, Volume: 85, Issue:6

    Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Molecular Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Tomography, X-Ray Computed

2014
[Importance of PET in surgery of esophageal cancer].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2014, Volume: 85, Issue:6

    Topics: Adenocarcinoma; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Response Evaluation Criteria in Solid Tumors

2014
Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review.
    Oncotarget, 2016, May-10, Volume: 7, Issue:19

    Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2016
Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?
    The British journal of radiology, 2016, Volume: 89, Issue:1065

    Topics: Ablation Techniques; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Observer Variation; Oncologists; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiologists; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; Tomography, X-Ray Computed; Treatment Outcome

2016

Trials

4 trial(s) available for fluorodeoxyglucose f18 and Response Evaluation Criteria in Solid Tumors

ArticleYear
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 12-15, Volume: 25, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Selection; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Radiopharmaceuticals; Receptor, ErbB-2; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2019
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
    British journal of cancer, 2018, Volume: 118, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA, Viral; Drug Monitoring; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Response Evaluation Criteria in Solid Tumors; Time Factors; Treatment Outcome; Tumor Burden; Viral Load

2018
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
    Journal of radiation research, 2015, Volume: 56, Issue:3

    Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome

2015
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Europe; Female; Fluorodeoxyglucose F18; Humans; Internationality; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome

2016

Other Studies

31 other study(ies) available for fluorodeoxyglucose f18 and Response Evaluation Criteria in Solid Tumors

ArticleYear
Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
    Nuclear medicine communications, 2022, Jun-01, Volume: 43, Issue:6

    Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiosurgery; Recurrence; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Treatment Outcome

2022
An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up.
    Annals of nuclear medicine, 2022, Volume: 36, Issue:6

    Topics: Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Treatment Outcome

2022
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
    Clinical lung cancer, 2020, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tumor Burden

2020
Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors

2020
The early prediction of pathological response to neoadjuvant chemotherapy and prognosis: comparison of PET Response Criteria in Solid Tumors and European Organization for Research and Treatment of Cancer criteria in breast cancer.
    Nuclear medicine communications, 2020, Volume: 41, Issue:3

    Topics: Adult; Aged; Breast Neoplasms; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors

2020
Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer.
    Cancer research and treatment, 2020, Volume: 52, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Ovarian Neoplasms; Ovary; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies

2020
[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
    Radiology and oncology, 2020, 07-29, Volume: 54, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors

2020
Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head & neck, 2021, Volume: 43, Issue:4

    Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck

2021
A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant article.
    Medicine, 2021, Apr-16, Volume: 100, Issue:15

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nivolumab; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Stomach Neoplasms

2021
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Jul-01, Volume: 28, Issue:7

    Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Risk Factors; Time Factors; Treatment Outcome

2017
Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Young Adult

2018
Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
    Academic radiology, 2018, Volume: 25, Issue:4

    Topics: Adult; Aged; Chemotherapy, Adjuvant; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Treatment Outcome

2018
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0.
    European journal of radiology, 2018, Volume: 101

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Infusions, Intravenous; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome; Tumor Burden

2018
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:10

    Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Response Evaluation Criteria in Solid Tumors

2018
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
    AJR. American journal of roentgenology, 2018, Volume: 211, Issue:5

    Topics: Aged; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Tumor Burden

2018
Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: FDG Uptake and Risk Stratification.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:2

    Topics: Adult; Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Response Evaluation Criteria in Solid Tumors; Risk Assessment

2019
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
    Nuclear medicine communications, 2019, Volume: 40, Issue:5

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes

2019
Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:7

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors

2019
Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Annals of surgical oncology, 2015, Volume: 22, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Conformal; Response Evaluation Criteria in Solid Tumors; Survival Rate; Tomography, X-Ray Computed

2015
Comparison of metabolic and anatomic response to chemotherapy based on PERCIST and RECIST in patients with advanced stage non-small cell lung cancer.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome

2015
Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies

2015
RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer.
    Journal of the National Cancer Institute. Monographs, 2015, Volume: 2015, Issue:51

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Triple Negative Breast Neoplasms

2015
Comparing RECIST with EORTC criteria in metastatic bladder cancer.
    Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

2016
Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy.
    Oncology, 2016, Volume: 90, Issue:2

    Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden

2016
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
    Radiology, 2016, Volume: 280, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2016
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    International journal of radiation oncology, biology, physics, 2016, Apr-01, Volume: 94, Issue:5

    Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiation Oncology; Radiology; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed

2016
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
    European journal of radiology, 2016, Volume: 85, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Analysis; Tumor Burden; Yttrium Radioisotopes

2016
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Survival Rate; Treatment Outcome

2016
PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Regression Analysis; Response Evaluation Criteria in Solid Tumors; Uterine Cervical Neoplasms

2016
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
    AJR. American journal of roentgenology, 2016, Volume: 207, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes

2016
Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
    European journal of radiology, 2017, Volume: 86

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2017